Alzamend Neuro lithium imaging data accepted for oral presentation
Alzamend Neuro says its Phase 1/2A lithium imaging data has been accepted for an oral presentation at the ISMRM Workshop on X-Nuclei MR in Barcelona, Spain.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.